NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Hygro, if 95% of the 331 patients had the mutant IDH type of GBM, there would have been about 314 patients that would have carried the mutant IDH GBM and only about 17 would have carried the wild type. That could be true in one in a million trials and here you are telling us that NWBO hit that jack pot. Everything about this trial seems to be extraordinary